VAXY SA
The score of VAXY shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +18 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VAXY's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 14,244 € | ||||
| Equity | −48,720 € | ||||
| Cash | 35,167 € | ||||
| EBITDA | 20,327 € | ||||
| Total assets | 313,346 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Mar 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 13 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 09 Jul 2022
VAXY's financial analysis
- Solvency-15.5%sector median: 33.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VAXY
VAXY's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.290.111
- VAT number
- BE0862290111
- Peppol
- Registered · 0208:0862290111 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Dec 2003
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 15 Mar 2026
- Activity
- Rental and operating of own or leased non-residential real estate, except land (NACE 68203)
VAXY (SA) has been based in Uccle since 2003, active in: rental and operating of own or leased non-residential real estate, except land. For 2025, it reports a net profit of 14,244 € and equity of −48,720 €; its revenue is not published. Its solvency stands at -15.5%, below the median of its sector (33.1%).
Companies similar to VAXY
Companies in the same business, of comparable size and area, outside its group.
- Nicoman Immo Rental and operating of own or leased real estate Chaudfontaine · balance sheet 263,375 €
- Soconavi Rental and operating of own or leased real estate Sprimont · balance sheet 342,678 €
- Stek. Rental and operating of own or leased real estate Ghent · balance sheet 296,214 €
- Twelve BOX Rental and operating of own or leased real estate Zaventem · balance sheet 380,546 €
- Offis Rental and operating of own or leased real estate Antwerp · balance sheet 288,001 €
- Hannic Rental and operating of own or leased real estate Ravels · balance sheet 239,377 €
- DE VIS Vastgoed & Investeringen Rental and operating of own or leased real estate Asse · balance sheet 237,581 €
- Orthopedie Tinel Rental and operating of own or leased real estate Deerlijk · balance sheet 227,028 €
Frequently asked questions about VAXY
What is the revenue of VAXY?
VAXY files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VAXY?
In Belgium, the VAT number is the company number prefixed with BE: BE0862290111 for VAXY, if the company is VAT-registered. Its company number (CBE) is 0862.290.111.
Where is the registered office of VAXY?
According to the CBE register, the registered office of VAXY is in 1180 Uccle.
What is the equity of VAXY?
At the close of the 2025 financial year, the equity of VAXY amounts to -48,720 €, a solvency of -15.5% of total assets.
Who manages VAXY?
The register lists 3 active mandates at VAXY. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VAXY
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →